A Phase I/IIa, Double-Blind, Placebo-Controlled Study Validating the Safety, Pharmacokinetics and Pharmacodynamic Profile of Sarconeos in Paediatric Patients with Duchenne Myopathy (MYODA-PK)

Trial Profile

A Phase I/IIa, Double-Blind, Placebo-Controlled Study Validating the Safety, Pharmacokinetics and Pharmacodynamic Profile of Sarconeos in Paediatric Patients with Duchenne Myopathy (MYODA-PK)

Planning
Phase of Trial: Phase I/II

Latest Information Update: 28 Mar 2018

At a glance

  • Drugs Sarconeos (Primary)
  • Indications Duchenne muscular dystrophy
  • Focus Pharmacokinetics
  • Acronyms MYODA-PK
  • Sponsors Biophytis
  • Most Recent Events

    • 28 Mar 2018 According to a Biophytis media release, this study could be launched in the second half of 2018.
    • 23 Mar 2018 New trial record
    • 20 Mar 2018 According to a Biophytis media release, this study is expected to begin in 2018 and data collected from this study will be used to assess dosage for the phase II/III clinical trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top